Home
Neurona Therapeutics

Neurona Therapeutics Market Share Analysis for August 2026

neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases

Jobs and Career > Human Resources

Domainneuronatherapeutics.com

Year Founded2008

Employees51 - 200

Annual Revenue$10M - $15M

Neurona Therapeutics

Neurona Therapeutics (including company regionals)

neuronatherapeutics.com

See more website traffic and engagement information

Neurona Therapeutics Revenue up to August 2026 is 10M - 15M

revenue generated by Neurona Therapeutics top domains

Neurona Therapeutics top domains revenue over 3 years

Revenue for Neurona Therapeutics top domains

neuronatherapeutics.com10M - 15M

See more with Sales Intelligence

Total visits to Neurona Therapeutics's top domains

Understand Neurona Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

neuronatherapeutics.com7.8K

See more with Sales Intelligence

Avg. visit duration in Neurona Therapeutics's top domains

Analyze Neurona Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

neuronatherapeutics.com00:00:38

See more with Sales Intelligence

Avg. pageviews on Neurona Therapeutics's top domains

See how Neurona Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

neuronatherapeutics.com3.19

See more with Sales Intelligence

Neurona Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

mesoblast.comCompany NameMesoblastEmployees51 - 200HQAustralia, MelbourneAnnual revenue$5M - $10MTotal visits8.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Neurona Therapeutics

These are the website technologies, by industry, used by Neurona Therapeutics top domains

Widget (2)

Twemoji

Audio Video Media (1)

Vimeo

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

5

See all

News & Signals from Neurona Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCandid Therapeutics, Inc. acquired Neurona Therapeutics for $650M on Apr 1st '26.For UCB, Candid follows closely behind Neurona Therapeutics, which the Belgian company acquired in mid-April for $650 million upfront and the promise of up to $500 million in milestones.

NewsNeurona Therapeutics, Inc. hired Eduardo Dunayevich as Chief Medical Officer on Nov 18th '25.SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) - Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Eduardo Dunayevich, M.D., as Chief Medical Officer.

NewsNeurona Therapeutics, Inc. attends event American Academy of Neurology Annual Meeting.Neurona Therapeutics Presents Positive Clinical Data Update from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy at American Academy of Neurology Annual Meeting.